Key facts
- It has raised $6.4M; the latest was Early Stage VC ($6.3M) in Jan 2025.
- Notable investors include Tech Incubator Program for Startup, KB Investment, Korea Investment Partners, SJ Investment Partners, Yuanta Investment — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Selta Square
- ·The full record, as it builds
Funding rounds
No funding rounds for Selta Square are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Selta Square
Developer of an intelligent pharmacovigilance platform designed to offer more active and innovative work. The company provides advanced AI and digital technologies and services so that pharmacovigilance experts can minimize repetitive tasks and focus on essential tasks, enabling users to systematically and scientifically operate adverse case management and medical evaluation of medicines.
- Sector
- Healthcare
- HQ
- Seongnam, South Korea
- Founded
- 2021
- Employees
- 18
- Website
- seltaglobal.com/
- Ownership
- Privately Held (backing)
Selta Square doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Selta Square shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Selta Square in its N-PORT filings yet. We sweep new filings monthly.